• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人眼部组织中流出转运蛋白的表达。

Expression of efflux transporters in human ocular tissues.

机构信息

State Key Laboratory Cultivation Base, Shandong Provincial Key Laboratory of Ophthalmology, Shandong Eye Institute, Shandong Academy of Medical Sciences, Qingdao, People's Republic of China.

出版信息

Drug Metab Dispos. 2013 Nov;41(11):1934-48. doi: 10.1124/dmd.113.052704. Epub 2013 Aug 26.

DOI:10.1124/dmd.113.052704
PMID:23979916
Abstract

To investigate the expression profiles of efflux transporters in human ocular tissues, quantitative real-time polymerase chain reaction, Western blotting, and immunohistochemistry were used to obtain the relative mRNA and protein expressions of various efflux transporters in human ocular tissues. The cornea, conjunctiva, iris-ciliary body (ICB), retina and choroid, human corneal epithelial cell line (HCEC), and human retinal pigment epithelial cell line (ARPE-19) were examined for the expressions of multidrug resistance-associated proteins 1-7 (MRP1-7), multidrug resistance 1 (MDR1) P-glycoprotein, lung resistance protein (LRP), and breast cancer-resistance protein (BCRP). The expression sites and patterns of efflux transporters were significantly different in ocular tissues, HCEC, and ARPE-19, as well as the expression profiles of efflux transporters in mRNA and protein levels in ocular tissues. At the protein level, MRP1-7, MDR1, and LRP were expressed in the corneal epithelium; MRP1-7, MDR1, LRP, and BCRP were expressed in the conjunctival epithelium; MRP1-2, MRP6-7, MDR1, and LRP were expressed in the ICB; MRP1-3, MRP6-7, MDR1, and LRP were expressed in the retina; MRP1-3, MRP6-7, MDR1, and LRP were expressed in the HCEC; and MRP7, MDR1, LRP, and BCRP were expressed in the ARPE-19. This quantitative and systematic study of efflux transporters in normal ocular tissues and cell lines provides evidence of cross-ocular tissue transporter expression differences, implying that efflux transporter expression variability should be taken into consideration for better understanding of ocular pharmacokinetic and pharmacodynamic data.

摘要

为了研究外排转运蛋白在人眼部组织中的表达谱,采用定量实时聚合酶链反应、Western 印迹和免疫组织化学方法,获得了人眼部组织中各种外排转运蛋白的相对 mRNA 和蛋白表达。检测了角膜、结膜、虹膜睫状体(ICB)、视网膜和脉络膜、人角膜上皮细胞系(HCEC)和人视网膜色素上皮细胞系(ARPE-19)中多药耐药相关蛋白 1-7(MRP1-7)、多药耐药蛋白 1(MDR1)P-糖蛋白、肺耐药蛋白(LRP)和乳腺癌耐药蛋白(BCRP)的表达。外排转运蛋白在眼部组织、HCEC 和 ARPE-19 中的表达部位和模式存在显著差异,并且在眼部组织中,mRNA 和蛋白水平的外排转运蛋白表达谱也存在差异。在蛋白水平,MRP1-7、MDR1 和 LRP 在角膜上皮细胞中表达;MRP1-7、MDR1、LRP 和 BCRP 在结膜上皮细胞中表达;MRP1-2、MRP6-7、MDR1 和 LRP 在 ICB 中表达;MRP1-3、MRP6-7、MDR1 和 LRP 在视网膜中表达;MRP1-3、MRP6-7、MDR1 和 LRP 在 HCEC 中表达;MRP7、MDR1、LRP 和 BCRP 在 ARPE-19 中表达。本研究对正常眼部组织和细胞系中外排转运蛋白进行了定量和系统的研究,为跨眼部组织转运体表达差异提供了证据,提示在更好地理解眼部药代动力学和药效学数据时,应考虑外排转运体表达的可变性。

相似文献

1
Expression of efflux transporters in human ocular tissues.人眼部组织中流出转运蛋白的表达。
Drug Metab Dispos. 2013 Nov;41(11):1934-48. doi: 10.1124/dmd.113.052704. Epub 2013 Aug 26.
2
Efflux protein expression in human retinal pigment epithelium cell lines.人视网膜色素上皮细胞系中的外排蛋白表达。
Pharm Res. 2009 Jul;26(7):1785-91. doi: 10.1007/s11095-009-9890-6. Epub 2009 Apr 21.
3
Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.多药耐药蛋白MDR1/P-糖蛋白、MRP1和LRP在急性髓系白血病中表达的频率及临床意义:西南肿瘤协作组研究
Blood. 1999 Aug 1;94(3):1086-99.
4
Expression of multidrug resistance associated transporters (MDR1, MRP1, LRP and BCRP) in porcine oocyte.猪卵母细胞中多药耐药相关转运蛋白(MDR1、MRP1、LRP和BCRP)的表达
Int J Mol Med. 2001 Apr;7(4):397-400. doi: 10.3892/ijmm.7.4.397.
5
Relevance of two genes in the multidrug resistance of hepatocellular carcinoma: in vivo and clinical studies.两个基因在肝细胞癌多药耐药性中的相关性:体内及临床研究
Tumori. 2010 Jan-Feb;96(1):90-6. doi: 10.1177/030089161009600115.
6
Expression of multidrug resistance-related transporters in human breast carcinoma.多药耐药相关转运蛋白在人乳腺癌中的表达
Jpn J Cancer Res. 2001 Apr;92(4):452-8. doi: 10.1111/j.1349-7006.2001.tb01115.x.
7
Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML).乳腺癌耐药蛋白(BCRP)在复发或难治性急性髓系白血病(AML)中的表达增加。
Leukemia. 2002 May;16(5):833-9. doi: 10.1038/sj.leu.2402496.
8
RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response.乳腺癌中乳腺癌耐药蛋白、肺耐药相关蛋白、多药耐药相关蛋白1和2以及多药耐药基因1的RNA表达:与化疗反应的相关性
Clin Cancer Res. 2003 Feb;9(2):827-36.
9
The roles of four multi-drug resistance proteins in hepatocellular carcinoma multidrug resistance.四种多药耐药蛋白在肝细胞癌多药耐药中的作用。
J Huazhong Univ Sci Technolog Med Sci. 2007 Apr;27(2):173-5. doi: 10.1007/s11596-007-0217-8.
10
Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia.多药耐药1(MDR1)、多药耐药相关蛋白1(MRP1)、肺耐药蛋白(LRP)和乳腺癌耐药蛋白(BCRP)基因的表达与儿童急性淋巴细胞白血病的临床结局
Int J Hematol. 2007 Aug;86(2):166-73. doi: 10.1532/IJH97.E0624.

引用本文的文献

1
Expanding Arsenal against Ocular Diseases through Nanoemulsion: Success So Far and the Road Ahead.通过纳米乳剂扩展抗眼部疾病的武器库:迄今为止的成功与未来之路。
Curr Drug Deliv. 2024 Jul 15. doi: 10.2174/0115672018286288240705064730.
2
Nanoparticle-based delivery systems as emerging therapy in retinoblastoma: recent advances, challenges and prospects.基于纳米颗粒的递送系统在视网膜母细胞瘤中的新兴疗法:最新进展、挑战与前景
Nanoscale Adv. 2023 Aug 15;5(18):4628-4648. doi: 10.1039/d3na00462g. eCollection 2023 Sep 12.
3
Ocular steroidome in human eyes and in eyes with complex central serous chorioretinopathy (CSCR).
人眼和复杂性中心性浆液性脉络膜视网膜病变(CSCR)眼中的眼类固醇组。
Sci Rep. 2023 Aug 29;13(1):14111. doi: 10.1038/s41598-023-41126-0.
4
Ocular Biodistribution of Once-Daily 0.6% Bilastine Eye Drops Reveals Highest Levels in Conjunctiva Up to 24 h Postadministration.每日一次 0.6%贝那利珠单抗滴眼液的眼部生物分布显示,给药后 24 小时内最高浓度在结膜。
J Ocul Pharmacol Ther. 2022 Nov;38(9):617-625. doi: 10.1089/jop.2022.0024. Epub 2022 Oct 21.
5
Bile Duct Ligation Impairs Function and Expression of Mrp1 at Rat Blood-Retinal Barrier via Bilirubin-Induced P38 MAPK Pathway Activations.胆管结扎通过胆红素诱导的 P38MAPK 通路激活损害血视网膜屏障 Mrp1 的功能和表达。
Int J Mol Sci. 2022 Jul 11;23(14):7666. doi: 10.3390/ijms23147666.
6
Lipid Nanoparticles as a Promising Drug Delivery Carrier for Topical Ocular Therapy-An Overview on Recent Advances.脂质纳米颗粒作为用于局部眼部治疗的有前景的药物递送载体——近期进展综述
Pharmaceutics. 2022 Feb 27;14(3):533. doi: 10.3390/pharmaceutics14030533.
7
Drug Delivery Challenges and Current Progress in Nanocarrier-Based Ocular Therapeutic System.基于纳米载体的眼部治疗系统中的药物递送挑战与当前进展
Gels. 2022 Jan 28;8(2):82. doi: 10.3390/gels8020082.
8
Pharmacological inhibition of MERTK induces in vivo retinal degeneration: a multimodal imaging ocular safety assessment.药物抑制 MER TK 可诱导体内视网膜变性:一种多模态成像眼部安全性评估。
Arch Toxicol. 2022 Feb;96(2):613-624. doi: 10.1007/s00204-021-03197-8. Epub 2022 Jan 1.
9
Role of Multidrug Resistance Proteins in Nonresponders to Immunomodulatory Therapy for Noninfectious Uveitis.多药耐药蛋白在非感染性葡萄膜炎免疫调节治疗无反应者中的作用
Transl Vis Sci Technol. 2020 Apr 18;9(5):12. doi: 10.1167/tvst.9.5.12. eCollection 2020 Apr.
10
Review of Intraocular Pharmacokinetics of Anti-Infectives Commonly Used in the Treatment of Infectious Endophthalmitis.感染性眼内炎常用抗感染药物的眼内药代动力学综述
Pharmaceutics. 2018 May 29;10(2):66. doi: 10.3390/pharmaceutics10020066.